Table of Contents
Influenza Research and Treatment
Volume 2011, Article ID 579597, 14 pages
http://dx.doi.org/10.1155/2011/579597
Research Article

Predictive and Reactive Distribution of Vaccines and Antivirals during Cross-Regional Pandemic Outbreaks

Department of Industrial and Management Systems Engineering, University of South Florida, Tampa, FL 33620, USA

Received 14 July 2010; Revised 30 January 2011; Accepted 21 March 2011

Academic Editor: Lance Jennings

Copyright © 2011 Andrés Uribe-Sánchez and Alex Savachkin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO), “Cumulative number of confirmed human cases of Avian Influenza A(H5N1) reported to WHO,” 2010, http://www.who.int/csr/disease/avian_Influenza/country/cases_table_2010_07_05/en/index.html.
  2. World Health Organization, “Pandemic (H1N1),” 2009, http://www.who.int/csr/don/2010_07_02/en/index.html.
  3. A. Schoenstadt, “Spanish Flu,” 2009, http://flu.emedtv.com/spanish-flu/spanish-flu.html.
  4. D. S. Fedson, “Pandemic Influenza and the global vaccine supply,” Clinical Infectious Diseases, vol. 36, no. 12, pp. 1552–1561, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Aunins, A. Lee, and D. Volkin, Vaccine Production, CRC Press, Boca Raton, Fla, USA, 2nd edition, 2000.
  6. World Health Organization, “Pandemic (h1n1) vaccine deployment,” 2009, http://www.who.int/csr/disease/swineflu/vaccines/h1n1_vaccination_deployment_update_20091217.pdf.
  7. WHO Global Influenza Programme, “Pandemic Influenza preparedness and response,” Tech. Rep., World Health Organization, Lyon, France, 2009. View at Google Scholar
  8. Centers for Disease Control and Prevention (CDC), “Preparing for pandemic Influenza,” 2007, http://www.cdc.gov/flu/pandemic/preparedness.htm.
  9. U.S. Department of Health & Human Services, “HHS pandemic influenza plan,” 2007, http://www.hhs.gov/pandemicflu/plan/.
  10. A. Handel, I. Longini, and R. Antia, “Towards a quantitative understanding of the within-host dynamics of Influenza A infections,” Epidemics, vol. 1, no. 3, pp. 185–195, 2009. View at Google Scholar
  11. B. Pourbohloul, A. Ahued, B. Davoudi et al., “Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America,” Influenza and other Respiratory Viruses, vol. 3, no. 5, pp. 215–222, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. P. Atkinson and L. M. Wein, “Quantifying the routes of transmission for pandemic Influenza,” Bulletin of Mathematical Biology, vol. 70, no. 3, pp. 820–867, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. E. Pitzer, S. J. Olsen, C. T. Bergstrom, S. F. Dowell, and M. Lipsitch, “Little evidence for genetic susceptibility to Influenza A (H5N1) from family clustering data,” Emerging Infectious Diseases, vol. 13, no. 7, pp. 1074–1076, 2007. View at Google Scholar · View at Scopus
  14. V. E. Pitzer, G. M. Leung, and M. Lipsitch, “Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China,” American Journal of Epidemiology, vol. 166, no. 3, pp. 355–363, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. Y. Yang, J. D. Sugimoto, M. Elizabeth Halloran et al., “The transmissibility and control of pandemic Influenza a (H1N1) virus,” Science, vol. 326, no. 5953, pp. 729–733, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. Yang, M. E. Halloran, J. D. Sugimoto, and I. M. Longini, “Detecting human-to-human transmission of avian Influenza A (H5N1),” Emerging Infectious Diseases, vol. 13, no. 9, pp. 1348–1353, 2007. View at Google Scholar · View at Scopus
  17. S. Cauchemez, F. Carrat, C. Viboud, A. J. Valleron, and P. Y. Boëlle, “A Bayesian MCMC approach to study transmission of Influenza: application to household longitudinal data,” Statistics in Medicine, vol. 23, no. 22, pp. 3469–3487, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. V. Colizza, A. Barrat, M. Barthélemy, and A. Vespignani, “The role of the airline transportation network in the prediction and predictability of global epidemics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2015–2020, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. M. Epstein, J. Parker, D. Cummings, and R. A. Hammond, “Coupled contagion dynamics of fear and disease: mathematical and computational explorations,” PLoS ONE, vol. 3, no. 12, Article ID e3955, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. E. Halloran, “Invited commentary: challenges of using contact data to understand acute respiratory disease transmission,” American Journal of Epidemiology, vol. 164, no. 10, pp. 945–946, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. F. G. Ball and O. D. Lyne, “Optimal vaccination policies for stochastic epidemics among a population of households,” Mathematical Biosciences, vol. 177-178, pp. 333–354, 2002. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  22. N. G. Becker and D. N. Starczak, “Optimal vaccination strategies for a community of households,” Mathematical Biosciences, vol. 139, no. 2, pp. 117–132, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Carrat, A. Lavenu, S. Cauchemez, and S. Deleguer, “Repeated Influenza vaccination of healthy children and adults:borrow now, pay later?” Epidemiology and Infection, vol. 134, no. 1, pp. 63–70, 2005. View at Google Scholar
  24. N. M. Ferguson, S. Mallett, H. Jackson, N. Roberts, and P. Ward, “A population-dynamic model for evaluating the potential spread of drug-resistant Influenza virus infections during community-based use of antivirals,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 4, pp. 977–990, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. P. Y. Lee, D. B. Matchar, D. A. Clements, J. Huber, J. D. Hamilton, and E. D. Peterson, “Economic analysis of Influenza vaccination and antiviral treatment for healthy working adults,” Annals of Internal Medicine, vol. 137, no. 4, pp. 225–231, 2002. View at Google Scholar · View at Scopus
  26. M. Lipsitch, T. Cohen, M. Murray, and B. R. Levin, “Antiviral resistance and the control of pandemic Influenza,” PLoS Medicine, vol. 4, no. 1, pp. 111–121, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. G. J. Milne, J. K. Kelso, H. A. Kelly, S. T. Huband, and J. McVernon, “A small community model for the transmission of infectious diseases: comparison of School closure as an intervention in individual-based models of an Influenza pandemic,” PLoS ONE, vol. 3, no. 12, Article ID e4005, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. H. Yasuda and K. Suzuki, “Measures against transmission of pandemic H1N1 Influenza in Japan in 2009: simulation model,” Euro Surveillance : Bulletin Européen sur les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 14, no. 44, 2009. View at Google Scholar · View at Scopus
  29. G. Miller, S. Randolph, and J. E. Patterson, “Responding to simulated pandemic Influenza in San Antonio, Texas,” Infection Control and Hospital Epidemiology, vol. 29, no. 4, pp. 320–326, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. K. Kelso, G. J. Milne, and H. Kelly, “Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of Influenza,” BMC Public Health, vol. 9, article 117, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. N. Halder, J. Kelso, and G. Milne, “Analysis of the effectiveness of interventions used during the 2009 A/H1N1 Influenza pandemic,” BioMed Central, vol. 10, article 168, 2010. View at Google Scholar
  32. D. O. Scharfstein, M. E. Halloran, H. Chu, and M. J. Daniels, “On estimation of vaccine efficacy using validation samples with selection bias,” Biostatistics, vol. 7, no. 4, pp. 615–629, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. R. J. Glass, L. M. Glass, W. E. Beyeler, and H. J. Min, “Targeted social distancing design for pandemic Influenza,” Emerging Infectious Diseases, vol. 12, no. 11, pp. 1671–1681, 2006. View at Google Scholar · View at Scopus
  34. K. R. Nigmatulina and R. C. Larson, “Living with Influenza: impacts of government imposed and voluntarily selected interventions,” European Journal of Operational Research, vol. 195, no. 2, pp. 613–627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. M. Longini, M. E. Halloran, A. Nizam, and Y. Yang, “Containing pandemic Influenza with antiviral agents,” American Journal of Epidemiology, vol. 159, no. 7, pp. 623–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. T. Wu, S. Riley, C. Fraser, and G. M. Leung, “Reducing the impact of the next Influenza pandemic using household-based public health interventions,” PLoS Medicine, vol. 3, no. 9, pp. 1532–1540, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. C. E. Mills, J. M. Robins, and M. Lipsitch, “Transmissibility of 1918 pandemic Influenza,” Nature, vol. 432, no. 7019, pp. 904–906, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. Patel, I. M. Longini, and M. E. Halloran, “Finding optimal vaccination strategies for pandemic Influenza using genetic algorithms,” Journal of Theoretical Biology, vol. 234, no. 2, pp. 201–212, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at MathSciNet · View at Scopus
  39. V. Colizza, A. Barrat, M. Barthelemy, A. J. Valleron, and A. Vespignani, “Modeling the worldwide spread of pandemic Influenza: baseline case and containment interventions,” PLoS Medicine, vol. 4, no. 1, pp. 95–110, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. P. Cooley, L. Ganapathi, G. Ghneim, S. Holmberg, W. Wheaton, and C. R. Hollingsworth, “Using Influenza-like illness data to reconstruct an Influenza outbreak,” Mathematical and Computer Modelling, vol. 48, no. 5-6, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. D. L. Chao, M. E. Halloran, V. J. Obenchain, and I. M. Longini, “FluTE, a publicly available stochastic Influenza epidemic simulation model,” PLoS Computational Biology, vol. 6, no. 1, Article ID e1000656, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. National Institute of General Medical Sciences, “Models of Infectious Disease Agent Study,” 2008, http://www.nigms.nih.gov/Initiatives/MIDAS/.
  43. N. M. Ferguson, D. A. T. Cummings, S. Cauchemez et al., “Strategies for containing an emerging Influenza pandemic in Southeast Asia,” Nature, vol. 437, no. 7056, pp. 209–214, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. I. M. Longini, A. Nizam, S. Xu et al., “Containing pandemic Influenza at the source,” Science, vol. 309, no. 5737, pp. 1083–1087, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. N. M. Ferguson, D. A. T. Cummings, C. Fraser, J. C. Cajka, P. C. Cooley, and D. S. Burke, “Strategies for mitigating an Influenza pandemic,” Nature, vol. 442, no. 7101, pp. 448–452, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. T. C. Germann, K. Kadau, I. M. Longini, and C. A. Macken, “Mitigation strategies for pandemic Influenza in the United States,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 15, pp. 5935–5940, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. S. Eubank, H. Guclu, V. S. A. Kumar et al., “Modelling disease outbreaks in realistic urban social networks,” Nature, vol. 429, no. 6988, pp. 180–184, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. E. Halloran, N. M. Ferguson, S. Eubank et al., “Modeling targeted layered containment of an Influenza pandemic in the United States,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 12, pp. 4639–4644, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. MIDAS, “Report from the Models of Infectious Disease Agent Study (MIDAS) Steering Committee,” 2004, http://www.nigms.nih.gov/News/Reports/midas_steering_050404.htm.
  50. Committee on Modeling Community Containment for Pandemic Influenza, “Modeling community containment for pandemic Influenza: a letter report,” 2006, http://www.nap.edu/catalog/11800.html.
  51. Centers for Disease Control and Prevention (CDC), “Interim pre-pandemic planning guidance: community strategy for pandemic Influenza mitigation in the United States,” 2007, http://www.pandemicflu.gov/professional/community/community_mitigation.pdf.
  52. M. I. Meltzer, N. J. Cox, and K. Fukuda, “The economic impact of pandemic Influenza in the United States: priorities for intervention,” Emerging Infectious Diseases, vol. 5, no. 5, pp. 659–671, 1999. View at Google Scholar · View at Scopus
  53. T. Das and A. Savachkin, “A large scale simulation model for assessment of societal risk and development of dynamic mitigation strategies,” IIE Transactions, vol. 40, no. 9, pp. 893–905, 2008. View at Google Scholar
  54. Colardo Department of Human Services Division of Mental Health, “Pandemic Influenza: quarantine, isolation and social distancing,” 2009, http://www.flu.gov/news/colorado_toolbox.pdf.
  55. J. T. Wu, S. Riley, and G. M. Leung, “Spatial considerations for the allocation of pre-pandemic Influenza vaccination in the United States,” Proceedings of the Royal Society B: Biological Sciences, vol. 274, no. 1627, pp. 2811–2817, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. J. Lawless and J. Lawless, Statistical Models and Methods for Lifetime Data, John Wiley & Sons, New York, NY, USA, 1982.
  57. O. Diekmann and J. Heesterbeek, Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation, John Wiley & Sons, New York, NY, USA, 2000.
  58. J. F. Brundage and G. D. Shanks, “Deaths from bacterial pneumonia during 1918-19 Influenza pandemic,” Emerging Infectious Diseases, vol. 14, no. 8, pp. 1193–1199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. Centers for Disease Control and Prevention (CDC), “CDC Influenza operational plan,” 2006, http://www.cdc.gov/flu/pandemic/cdcplan.htm.
  60. World Health Organization (WHO), “WHO guidelines on the use of vaccine and antivirals during Influenza pandemics,” 2004, http://www.who.int/csr/resources/publications/Influenza/11_29_01_A.pdf.
  61. S. Pasteur, “Influenza A(H1N1) Monovalent Vaccine,” 2009, http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm182404.pfd.
  62. R. J. Blendon, L. M. Koonin, J. M. Benson et al., “Public response to community mitigation measures for pandemic Influenza,” Emerging Infectious Diseases, vol. 14, no. 5, pp. 778–786, 2008. View at Google Scholar · View at Scopus
  63. M. Z. Sadique, W. J. Edmunds, R. D. Smith et al., “Precautionary behavior in response to perceived threat of pandemic Influenza,” Emerging Infectious Diseases, vol. 13, no. 9, pp. 1307–1313, 2007. View at Google Scholar · View at Scopus
  64. R. Maunder, J. Hunter, L. Vincent et al., “The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital,” Canadian Medical Association Journal, vol. 168, no. 10, pp. 1245–1251, 2003. View at Google Scholar · View at Scopus
  65. E. Robertson, K. Hershenfield, S. L. Grace, and D. E. Stewart, “The psychosocial effects of being quarantined following exposure to SARS: a qualitative study of Toronto health care workers,” Canadian Journal of Psychiatry, vol. 49, no. 6, pp. 403–407, 2004. View at Google Scholar
  66. M. Pearson, C. Bridges, and S. Harper, “Influenza vaccination of health-care personnel,” MMWR, vol. 55, no. 2, pp. 1–16, 2006. View at Google Scholar
  67. M. T. Keane, M. V. Walter, B. I. Patel et al., “Confidence in vaccination: a parent model,” Vaccine, vol. 23, no. 19, pp. 2486–2493, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. V. P. Niederhauser, G. Baruffi, and R. Heck, “Parental decision-making for the varicella vaccine,” Journal of Pediatric Health Care, vol. 15, no. 5, pp. 236–243, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. S. D. Rhodes and K. C. Hergenrather, “Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers,” Preventive Medicine, vol. 35, no. 2, pp. 128–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. S. L. Rosenthal, R. K. Kottenhahn, F. M. Biro, and P. A. Succop, “Hepatitis B vaccine acceptance among adolescents and their parents,” Journal of Adolescent Health, vol. 17, no. 4, pp. 248–254, 1995. View at Publisher · View at Google Scholar · View at Scopus
  71. M. S. Smailbegovic, G. J. Laing, and H. Bedford, “Why do parents decide against immunization? The effect of health beliefs and health professionals,” Child: Care, Health and Development, vol. 29, no. 4, pp. 303–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Safranek, D. Lawrence, L. Kuriand et al., “Reassessment of the association between Guillain-Barré syndrome and receipt of swine Influenza vaccine in 1976-1977: results of a two-state study,” American Journal of Epidemiology, vol. 133, no. 9, p. 940, 1991. View at Google Scholar
  73. K. M. Cummings, A. M. Jette, B. M. Brock, and D. P. Haefner, “Psychosocial determinants of immunization behavior in a swine Influenza campaign,” Medical Care, vol. 17, no. 6, pp. 639–649, 1979. View at Google Scholar · View at Scopus
  74. The New Yorker, “The fear factor,” 2009, http://www.newyorker.com/talk/comment/2009/10/12/091012taco_talk_specter.
  75. The New York Times, “Doctors swamped by swine flu vaccine fears,” 2009, http://www.msnbc.msn.com/id/33179695/ns/health-swine_flu/.
  76. A. Gosavi, T. K. Das, and S. Sarkar, “A simulation based learning automata framework for solving semi-Markov decision problems under long run average reward,” IIE Transactions in Operations Engineering, vol. 36, no. 6, pp. 557–567, 2001. View at Google Scholar
  77. A. Savachkin, A. Uribe-Sánchez, T. Das, D. Prieto, A. Santana, and D. Martinez, “Supplemental data and model parameter values for cross-regional simulation-based optimization testbed,” 2010, http://imse.eng.usf.edu/pandemic/supplement.pdf.
  78. U.S Census Bureau, “2001 American community survey,” 2000, http://www.census.gov/prod/2001pubs/statab/sec01.pdf.
  79. Bureau of transportation statistics, “2001 National household travel survey (NTHS),” 2002, http://www.bts.gov/programs/national_household_travel_survey/.
  80. “Tampa International Airport: daily traffic volume data,” 2010, http://www.tampaairport.com.
  81. “Miami International Airport: daily traffic volume data,” 2010, http://www.miami-airport.com.
  82. “Miami International Airport: daily traffic volume data,” 2010, http://www.jaa.aero/General/Default.
  83. “Tallahassee Regional Airport: daily traffic volume data,” 2010, http://www.talgov.com/airport/index.cfm.
  84. “How thermal-imaging cameras spot flu fevers,” 2010, http://www.msnbc.msn.com/id/30523865/.
  85. Writing committee of the World Health Organization (WHO), “Consultation on human Influenza A/H5.Avian Influenza A(H5N1) infection in humans,” The New England Journal of Medicine, vol. 353, no. 13, pp. 1374–1385, 2005. View at Google Scholar
  86. Institute of Medicine (IOM), Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program, The National Academies Press, Washington, DC, USA, 2008.
  87. J. J. Treanor, J. D. Campbell, K. M. Zangwill, T. Rowe, and M. Wolff, “Safety and immunogenicity of an inactivated subvirion Influenza A (H5N1) vaccine,” The New England Journal of Medicine, vol. 354, no. 13, pp. 1343–1351, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. R. J. Blendon, C. M. DesRoches, M. S. Cetron, J. M. Benson, T. Meinhardt, and W. Pollard, “Attitudes toward the use of quarantine in a public health emergency in four countries,” Health Affairs, vol. 25, no. 2, pp. 15–25, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. D. Montgomery, Design and Analysis of Experiments, John Wiley & Sons, New York, NY, USA, 2007.
  90. T. Halfhill, “Inflation calculator,” 2009, http://www.halfhill.com/inflation.html.
  91. D. Bell, A. Nicoll, K. Fukuda et al., “Nonpharmaceutical interventions for pandemic Influenza, national and community measures,” Emerging Infectious Diseases, vol. 12, no. 1, pp. 88–94, 2006. View at Google Scholar · View at Scopus